Aquestive Therapeutics
AQST
#6983
Rank
โ‚น34.19 B
Marketcap
โ‚น375.06
Share price
-2.84%
Change (1 day)
183.57%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2024 (TTM): โ‚น4.86 Billion

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น4.92 Billion. In 2023 the company made a revenue of โ‚น4.21 Billion an increase over the revenue in the year 2022 that were of โ‚น3.94 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น4.86 B15.45%
2023 โ‚น4.21 B6.73%
2022 โ‚น3.94 B4.28%
2021 โ‚น3.78 B12.83%
2020 โ‚น3.35 B-10.62%
2019 โ‚น3.75 B-20.43%
2018 โ‚น4.71 B10.35%
2017 โ‚น4.27 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.09 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น60.51 B 1,127.50%๐Ÿ‡บ๐Ÿ‡ธ USA